Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention

Journal of the American College of Cardiology

Volumn 46, Issue 2, 2005, Pages 284-290

  Huczek, Zenon ^a   Kochman, Janusz ^a   Filipiak, Krzysztof J ^a   Horszczaruk, Grzegorz J ^a   Grabowski, Marcin ^a   Piatkowski, Radoslaw ^a   Wilczynska, Joanna ^a   Zielinski, Andrzej ^a   Meier, Bernhard ^b   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; ST SEGMENT ELEVATION; SURVIVAL RATE; THROMBOCYTE VOLUME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; BLOOD CELL COUNT; BLOOD PLATELETS; CELL SIZE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 22044443870     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.03.065     Document Type: Article

References (32)

1. B. Van der Loo, J.F. Martin A role for changes in platelet production in the cause of acute coronary syndromes Arterioscler Thromb Vasc Biol 19 1999 672 679
2. J.F. Martin, E.A. Towbridge, G.L. Salmon, J. Plumb The biological significance of platelet volume its relationship to bleeding time, platelet thromboxane B2 production and megacaryocyte nuclear DNA concentration Thromb Res 32 1983 443 460
3. J.A. Jakubowski, C.B. Thompson, R. Vaillancourt, C.R. Valeri, D. Deykin Arachidonic acid metabolism by platelets of differing size Br J Haematol 53 1983 503 511
4. C.B. Thompson, K.A. Eaton, S.M. Princiotta, C.A. Rushin, C.R. Valeri Size dependent platelet subpopulations relationship of platelet volume to ultrastructure, enzymatic activity and function Br J Haematol 50 1982 509 519
5. D. Tschoepe, P. Rosen, L. Kaufmann Evidence for abnormal platelet glycoprotein expression in diabetes mellitus Eur J Clin Invest 20 1990 166 170
6. H. Giles, R.E.A. Smith, J.F. Martin Platelet glycoprotein IIb/IIIa and size are increased in acute myocardial infarction Eur J Clin Invest 24 1994 69 72
7. H.P. Cameron, R.M. Ibbotson, P.H.M. Carson Platelet size in myocardial infarction Br Med J 287 1983 449 451
8. L. Pizzuli, A. Yang, J.F. Martin, B. Luderitz Changes in platelet size and count in unstable angina compared to stable or non-cardiac chest pain Eur Heart J 19 1998 80 84
9. G. Endler, A. Klimesch, A. Saunder-Plassman Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease Br J Haematol 117 2002 399 404
10. P. Bath, C. Algert, N. Chapman, B. Neal Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease Stroke 35 2004 622 626
11. J. Martin, P.M.W. Bath, M.L. Burr Increased platelet size following myocardial infarction is associated with subsequent death and non-fatal reinfarction Lancet 338 1991 1409 1411
12. P. Pabon, F. Nieto, J.L. Morinigo The effect of mean platelet volume on the short-term prognosis of acute myocardial infarction Rev Esp Cardiol 51 1998 816 822
13. S. Greisenegger, G. Endler, H. Hsieh, S. Tentschert, C. Mannhalter, W. Lalouschek Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35 2004 1688 1691
14. C.M. Gibson, C.P. Cannon, W.L. Daley TIMI frame count a quantitive method of assessing coronary artery flow Circulation 93 1996 879 888
15. E. Al-Mousa, J.T. Dodge, M. Rizzo The TIMI frame count in saphenous vein grafts Am Heart J 135 1998 323 328
16. G.W. Stone, C.L. Grines, K.F. Browne Predictors of in-hospital and 6 month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial J Am Coll Cardiol 25 1995 370 377
17. I. Morishima, T. Sone, K. Okumura Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction J Am Coll Cardiol 36 2000 1202 1209
18. H. Ito, A. Maruyama, K. Iwakura Clinical implications of "no-reflow" phenomenon a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction Circulation 93 1996 223 228
19. T. Reffelman, R.A. Kloner The "no-reflow" phenomenon basic science and clinical correlates Heart 87 2002 162 168
20. S.H. Rezkalla, R.A. Kloner No-reflow phenomenon Circulation 105 2002 656 662
21. C.M. Gibson, S.A. Murphy, M.J. Rizzo Relationship between TIMI frame count and clinical outcomes after thrombolytic administration Circulation 99 1999 1945 1950
22. S. Tsiara, M. Elisaf, I.A. Jagroop, D.P. Mikhailidis Platelets as predictors of vascular risk is there a practical index of platelet activity? Clin Appl Thromb Hemost 9 2003 177 190
23. F.A. Cura, P.L. L'Alier, S.R. Kapadia Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction Am J Cardiol 88 2001 124 128
24. H.K. Yip, M.C. Chen, H.W. Ghang Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction Chest 122 2002 1322 1332
25. M. Grabowski, K.J. Filipiak, G. Karpinski Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST elevation myocardial infarction treated with primary angioplasty Am Heart J 148 2004 655 662
26. M.J. Eisenberg, S. Jamal Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction J Am Coll Cardiol 42 2003 1 6
27. B.A. Vakili, R.C. Kaplan, J.N. Slater A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention Am J Cardiol 91 2003 946 995
28. S. Steiner, D. Seidinger, K. Huber, C. Kaun, E. Minar, C.W. Kopp Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression Arterioscler Thromb Vasc Biol 23 2003 1697 1702
29. F.J. Neumann, D. Zohlnhofer, L. Fakhoury, I. Ott, M. Gawaz, A. Schomig Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction J Am Coll Cardiol 34 1999 1420 1426
30. P.M. Bath, R.J. Butterworth Platelet size measurement, physiology and vascular disease Blood Coagul Fibrinolysis 7 1996 157 161
31. M.B. Yilmaz, E. Saricam, S.F. Biyikoglu Mean platelet volume and exercise stress test J Thromb Thrombolysis 17 2004 115 120
32. Z. Hekimsoy, B. Payzin, T. Ornek, G. Kandogan Mean platelet volume in type 2 diabetic patients J Diabetes Complications 18 2004 173 176